Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 69, 2005 - Issue 10
Journal homepage
158
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

RKTS-33, an Epoxycyclohexenone Derivative That Specifically Inhibits Fas Ligand-Dependent Apoptosis in CTL-Mediated Cytotoxicity

Tomokazu MITSUICenter for Biological Resources and Informatics, Tokyo Institute of Technology
,
Yasunobu MIYAKECenter for Biological Resources and Informatics, Tokyo Institute of Technology;Antibiotics Laboratory, Discovery Research Institute, RIKEN
,
Hideaki KAKEYAAntibiotics Laboratory, Discovery Research Institute, RIKEN
,
Yujiro HAYASHIDepartment of Industrial Chemistry, Faculty of Engineering, Tokyo University of Science
,
Hiroyuki OSADAAntibiotics Laboratory, Discovery Research Institute, RIKEN
&
Takao KATAOKACenter for Biological Resources and Informatics, Tokyo Institute of Technology
Pages 1923-1928 | Received 09 May 2005, Accepted 07 Jun 2005, Published online: 22 May 2014

  • 1) Barry, M., and Bleackley, R. C., Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol., 2, 401–409 (2002).
  • 2) Russell, J. H., and Ley, T. J., Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol., 20, 323–370 (2002).
  • 3) Metkar, S. S., Wang, B., Aguilar-Santelises, M., Raja, S. M., Uhlin-Hansen, L., Podack, E., Trapani, J. A., and Froelich, C. J., Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity, 16, 417–428 (2002).
  • 4) Trapani, J. A., and Sutton, V. R., Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol., 15, 533–543 (2003).
  • 5) Lieberman, J., and Fan, Z., Nuclear war: the granzyme A-bomb. Curr. Opin. Immunol., 15, 553–559 (2003).
  • 6) Nagata, S., Apoptosis by death factor. Cell, 88, 355–365 (1997).
  • 7) Krammer, P. H., CD95’s deadly mission in the immune system. Nature, 407, 789–795 (2000).
  • 8) Miyake, Y., Kakeya, H., Kataoka, T., and Osada, H., Epoxycyclohexenone inhibits Fas-mediated apoptosis by blocking activation of pro-caspase-8 in the death-inducing signaling complex. J. Biol. Chem., 278, 11213–11220 (2003).
  • 9) Mitsui, T., Miyake, Y., Kakeya, H., Osada, H., and Kataoka, T., ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity. J. Immunol., 172, 3428–3436 (2004).
  • 10) Kakeya, H., Miyake, Y., Shoji, M., Kishida, S., Hayashi, Y., Kataoka, T., and Osada, H., Novel non-peptide inhibitors targeting death receptor-mediated apoptosis. Bioorg. Med. Chem. Lett., 13, 3743–3746 (2003).
  • 11) Staerz, U. D., Kanagawa, O., and Bevan, M. J., Hybrid antibodies can target sites for attack by T cells. Nature, 314, 628–631 (1985).
  • 12) Shinohara, N., Huang, Y. Y., and Muroyama, A., Specific suppression of antibody responses by soluble protein-specific, class II-restricted cytolytic T lymphocyte clones. Eur. J. Immunol., 21, 23–27 (1991).
  • 13) Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H., and Okumura, K., Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. U.S.A., 91, 4930–4934 (1994).
  • 14) Watanabe, M., Wegmann, D. R., Ochi, A., and Hozumi, N., Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten. Proc. Natl. Acad. Sci. U.S.A., 83, 5247–5251 (1986).
  • 15) Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S., and Nagai, K., Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol., 156, 3678–3686 (1996).
  • 16) Schneider, P., Holler, N., Bodmer, J. L., Hahne, M., Frei, K., Fontana, A., and Tschopp, J., Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med., 187, 1205–1213 (1998).
  • 17) Miwa, K., Hashimoto, H., Yatomi, T., Nakamura, N., Nagata, S., and Suda, T., Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. Int. Immunol., 11, 925–931 (1999).
  • 18) Takayama, H., Shinohara, N., Kawasaki, A., Someya, Y., Hanaoka, S., Kojima, H., Yagita, H., Okumura, K., and Shinkai, Y., Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones. Int. Immunol., 3, 1149–1156 (1991).
  • 19) Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H., and Nagata, S., Fas ligand in human serum. Nat. Med., 2, 317–322 (1996).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.